-
NIH Aug 1, 2003 | R13
Conference - Genetic Disease Research Need /Opportunity
Institution: American College of Medical Genetics
FOA Number: N/A
Abstract
The annual meeting of the American College of Medical Genetics (ACMG) brings together a large proportion of basic and clinical investigators of rare genetic diseases. The organizers propose a series of workshops to be held in conjunction with ACMG meetings to consider issues related to identifying needs and opportunities for collaborative research involving rare genetic diseases (RGDs) associated with birth defects, mental retardation and developmental disabilities, and would set the stage for clinical and translational research.
RGDs present many challenges to the development of effective research plans. These include infrastructure to identify and register patients with RGDs, their associated databases, identification and/or collection of biological specimens, coordination of rapidly evolving therapeutic interventions, and the coordination of studies of a usually limited number of experts involved with any individual rare condition with expertise from correlative sciences and other specialties. A coordinated and collaborative group would facilitate research into the epidemiology, intervention, and prevention of these rare conditions. It would allow for the integration of the many complementary programs overseen by non-NIH governmental organizations and agencies and, in association with currently funded NIH initiatives such as the Mental Retardation Research Centers and the National Children's Study, be highly synergistic with regard to RGD research.
The annual workshops over the five years of this application would evaluate the existing models for facilitating collaborative research such as the consortium and cooperative group models. Specific diseases or classes of diseases would be used to identify the research gaps in the current system, the types of research that would be enabled, and the issues that rare genetic diseases raise that drive the need for collaborative research. The workshops would bring together representatives of government agencies, basic and clinical researchers, consumers and families, women, minorities, and underserved populations and geneticists. The first workshop in March 2004 would focus on the current models for collaborative research, the needs and potential benefits of collaborative research for these conditions, and assess collaborative research systems for a specific disease such as the lysosomal storage diseases or cystic fibrosis. (Co-fund with NICHD)
FUNDING AGENCY:
Funder:
NIHInstitute:
EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTFunding Type:
R13Project Number:
R13HD044529Start Date:
Aug 1, 2003End Date:
Jul 31, 2008PROJECT TERMS:
Advertising, Air, American, Area, Biological, Child, Children's Oncology Group, Class, Clinical, Clinical Investigator, Clinical Research, Clinical Trials, Collection, college, Complement, condition, Congenital Abnormality, Consumer Participation, Country, Cystic Fibrosis, Databases, Development, Developmental Disabilities, Disease, disorder prevention, disorder risk, Educational workshop, Epidemiology, Ethnic group, Evaluation, Evolution, Family, Funding, Genetic, Genetic Risk, Genetic screening method, Genetic Services, Government Agencies, Group Structure, health care delivery, Health Resources, Health Services Accessibility, Hereditary Disease, Home environment, Incidence, Individual, Institution, Interest Group, Internet, intervention program, Journals, Laboratories, Lysosomal Storage Diseases, Mails, Medical Genetics, medical specialties, Medicine, Mental Retardation, Minority, Modeling, Mutation Spectra, National Children's Study, Neonatal Screening, novel therapeutics, Numbers, Orphan, Orphan Disease, Other Genetics, Patients, Peripheral, Personal Satisfaction, Population, Population Surveillance, Prevention intervention, Prevention strategy, Private Sector, Process, programs, Provider, Public Health, Publications, Qualifying, Range, Recommendation, Registries, Regulation, Reporting, Research, research and development, Research Infrastructure, Research Personnel, research study, Risk, Risk Factors, Role, Science, Series, Site, Specimen, Staging, symposium, System, systems research, tandem mass spectrometry, Technology, Testing, Therapeutic Intervention, Translational Research, Underserved Population, United States Dept. of Health and Human Services, United States Food and Drug Administration, United States National Institutes of Health, Woman